MLL5 may promote the tumour phenotype by suppressing differentiation, with its downregulation associated with the upregulation of GFAP and TUBB3, and MLL5 overexpression inhibiting immune response-related genes and interferon signalling pathways [129]. This evidence concerns the gene KMT2E and neoplasm.